Login to Your Account

Bayer buys into China’s lucrative TCM market

By Shannon Ellis
Staff Writer

Wednesday, March 5, 2014

SHANGHAI – Bayer AG is buying Dihon Pharmaceutical Group Co. located China’s southwest Yunnan province. Privately held Dihon makes OTC and traditional Chinese medicines (TCM) sold in China and Southeast Asia.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription